Paterna S, Martino S G, Campisi D, Cascio Ingurgio N, Marsala B A
Istituto di Clinica Medica Base, Università degli Studi di Palermo.
Clin Ter. 1990 Jul 31;134(2):119-25.
Notwithstanding progress in the prophylactic treatment of migraine, the available therapies are often inefficient and unsatisfactory. In this study, 50 patients suffering for at least one year from the classic or common type migraine and treated with calcium-antagonists: Verapamil, Flunarizine, Diltiazem, Nimodipine, as well as placebo, were studied. 34 patients completed the study. All of the calcium-antagonists studied resulted efficacious in the prophylaxis of migraine; however, more attention should be paid to Flunarizine since this substance, in addition to its therapeutic efficacy, also has the advantages of a single daily dose which makes it the drug of choice in the prophylaxis of vasomotor migraine.
尽管偏头痛的预防性治疗取得了进展,但现有的治疗方法往往效率低下且不尽人意。在本研究中,对50名患有典型或普通型偏头痛至少一年且接受钙拮抗剂(维拉帕米、氟桂利嗪、地尔硫卓、尼莫地平)以及安慰剂治疗的患者进行了研究。34名患者完成了研究。所有研究的钙拮抗剂在偏头痛预防方面均显示有效;然而,应更多关注氟桂利嗪,因为这种药物除了具有治疗效果外,还具有每日单次给药的优势,这使其成为血管舒缩性偏头痛预防的首选药物。